Martin Holkedahl

Martin Holkedahl is senior director quality at Novavax AB. Martin holds the operational and strategic responsibility for QC and QA that includes the testing and release of the Matrix-A™, Matrix-C™, Matrix-V™ and Matrix-M™ adjuvants.

In 2018, Martin joined Novavax AB as head of quality. Prior to working at Novavax AB, Martin has over 20 years’ experience from the industry with various positions in manufacturing and quality. Martin has a Master of Science degree in Chemical Engineering from the Royal Institute of Technology in Stockholm.